JP2024523730A5 - - Google Patents
Info
- Publication number
- JP2024523730A5 JP2024523730A5 JP2024501196A JP2024501196A JP2024523730A5 JP 2024523730 A5 JP2024523730 A5 JP 2024523730A5 JP 2024501196 A JP2024501196 A JP 2024501196A JP 2024501196 A JP2024501196 A JP 2024501196A JP 2024523730 A5 JP2024523730 A5 JP 2024523730A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- cdr3
- cdr1
- cdr2
- cdr sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163218919P | 2021-07-07 | 2021-07-07 | |
| US63/218,919 | 2021-07-07 | ||
| PCT/US2022/036422 WO2023283383A1 (en) | 2021-07-07 | 2022-07-07 | Antibody affinity maturation using natural liability-free cdrs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523730A JP2024523730A (ja) | 2024-06-28 |
| JP2024523730A5 true JP2024523730A5 (https=) | 2025-07-14 |
Family
ID=84801095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024501196A Pending JP2024523730A (ja) | 2021-07-07 | 2022-07-07 | 天然のライアビリティを含まないｃｄｒを使用した抗体親和性成熟 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20230167165A1 (https=) |
| EP (1) | EP4366773A4 (https=) |
| JP (1) | JP2024523730A (https=) |
| KR (1) | KR20240056488A (https=) |
| CN (1) | CN118103065A (https=) |
| WO (1) | WO2023283383A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8877688B2 (en) * | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| EP3246434A1 (en) * | 2015-01-13 | 2017-11-22 | Ewha University-Industry Collaboration Foundation | Method for preparing novel antibody library and library prepared thereby |
| EP3728705A4 (en) * | 2017-12-18 | 2022-01-19 | Charles River Laboratories, Inc. | RADICALLY DIVERSE HUMAN ANTIBODY LIBRARY |
| EP3833685A4 (en) * | 2018-07-08 | 2022-08-17 | Specifica Inc. | ANTIBODY LIBRARIES WITH FEATURES FOR MAXIMIZED ANTIBODY DEVELOPMENT |
-
2022
- 2022-07-07 US US17/860,041 patent/US20230167165A1/en active Pending
- 2022-07-07 EP EP22838437.6A patent/EP4366773A4/en active Pending
- 2022-07-07 KR KR1020247004521A patent/KR20240056488A/ko active Pending
- 2022-07-07 JP JP2024501196A patent/JP2024523730A/ja active Pending
- 2022-07-07 CN CN202280059228.0A patent/CN118103065A/zh active Pending
- 2022-07-07 US US18/577,398 patent/US20240384438A1/en active Pending
- 2022-07-07 WO PCT/US2022/036422 patent/WO2023283383A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7559126B2 (ja) | 抗ｖｉｓｔａ抗体および断片 | |
| JP2022008382A5 (https=) | ||
| JP2022507485A5 (https=) | ||
| JP2022529344A5 (https=) | ||
| JP2021508469A5 (https=) | ||
| JP2021531822A5 (https=) | ||
| JP2017518040A5 (https=) | ||
| JP2023145778A5 (https=) | ||
| JP2020525032A5 (https=) | ||
| JP2022553129A5 (https=) | ||
| JP2008532949A5 (https=) | ||
| RU2015145543A (ru) | Способы и композиции для лечения болезни дего | |
| IL295295A (en) | Antibodies targeting fc receptor-like 5 and methods of use | |
| RU2009128064A (ru) | Антитела к cd44 | |
| JP2012176953A5 (https=) | ||
| JP2016503067A5 (https=) | ||
| JP2024532489A5 (https=) | ||
| JP5405831B2 (ja) | Ｈ−ｃｄｒ３領域の新規集合体およびその使用 | |
| JP2022521705A5 (https=) | ||
| JP2017537082A5 (https=) | ||
| US20110223176A1 (en) | Basigin binding proteins | |
| JP2022505445A5 (https=) | ||
| JP2021520393A5 (https=) | ||
| AU2025259843A1 (en) | 4-1BB Binding Protein And Application Thereof | |
| JP2021503292A5 (https=) |